|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02335 MICOT PHARMA-B
Nominal 
() Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 |
| Property, plant, equip. & others | 6,622 | -28.147% | 9,216 |
| Land & other Lease Assets | 18,775 | 560.626% | 2,842 |
| Intangible Assets | 0 | -- | 0 |
| Interests in Asso. & JCEs | 0 | -- | 0 |
| Other Non-current Assets | 43,863 | -10.889% | 49,223 |
| 69,260 | 13.020% | 61,281 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | ||
| Inventories | 0 | -- | 0 | |
| Trade Receivables | 0 | -- | 0 | |
| Cash & Bank Balances | 80,556 | 24.582% | 64,661 | |
| Other Current Assets | 181,645 | 49.729% | 121,316 | |
| Assets Held for Sale | 0 | -- | 0 | |
| 262,201 | 40.986% | 185,977 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | |||
| Trade Payables | 3,538 | -54.236% | 7,731 | ||
| S-T Debt & Leases | 49,499 | 1131.625% | 4,019 | ||
| Other Current Liabilities | 213,370 | 222.399% | 66,182 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | ||
| 266,407 | 241.845% | 77,932 | |||
| Net Current Assets | (4,206) | -- | 108,045 | ||
| Total Assets Less Current Liabilities | 65,054 | -61.581% | 169,326 | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | ||||
| L-T Debt & Leases | 202 | -99.525% | 42,533 | |||
| Other Non-current Liabilities | 1,024,737 | -- | 0 | |||
| 1,024,939 | 2309.750% | 42,533 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | |||||
| Share Capital | 5,474 | 9.809% | 4,985 | ||||
| Reserves | (977,934) | -- | 106,826 | ||||
| Others | 0 | -- | 0 | ||||
| Shareholders' Funds | (972,460) | -- | 111,811 | ||||
| Non-controlling Interests | 12,575 | -16.066% | 14,982 | ||||
| Others | 0 | -- | 0 | ||||
| (959,885) | -- | 126,793 | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | |
| Commitments | 0 | -- | 0 |
| Contingent Liabilities | 0 | -- | 0 |
| Remarks: | Real time quote last updated: 17/06/2026 07:38 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -182,507 |
| %Change | 18.027% |
| EPS / (LPS) | RMB -- |
| NBV Per Share (¥) | RMB -- |